BBIO vs SNOW · rev $221.9M vs rev $4.68B
BridgeBio Pharma Inc (BBIO) versus Snowflake Inc. (SNOW) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Snowflake Inc. (SNOW) is a software - application company listed on US. It is led by Sridhar Ramaswamy.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
Latest reported SNOW revenue for 2026-01-31 was $4.68B. Net income was -$1.33B. Revenue was up 29.2% from 2025-01-31 to 2026-01-31. SNOW currently screens at market cap $73.90B.
BBIO currently screens at market cap $13.24B. SNOW currently screens at market cap $73.90B.
Not investment advice. Open the BBIO and SNOW stock pages for the full models.
Not investment advice.